Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series (Q82740000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21131943%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21131943%20AND%20SRC:MED&resulttype=core&format=json

https://api.crossref.org/works/10.1038/AJG.2010.363

17 January 2020

Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series (English)

1 reference

non-alcoholic steatohepatitis

19 November 2024

main subject

1 reference

Linda Ragozzino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21131943%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Naga Chalasani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21131943%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Patrick R. Kenny

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21131943

19 November 2024

Daniel E. Brady

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21131943

19 November 2024

Dawn M. Torres

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21131943

19 November 2024

Stephen A. Harrison

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21131943

19 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21131943

19 November 2024

publication date

1 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21131943%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

December 2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21131943

full work available at URL

19 November 2024

http://www.nature.com/articles/ajg2010363.pdf

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.363

http://www.nature.com/articles/ajg2010363

19 November 2024

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.363

https://journals.lww.com/00000434-201012000-00039

19 November 2024

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.363

The American Journal of Gastroenterology

19 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21131943%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21131943%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21131943%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

2707-2709

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21131943%20AND%20SRC:MED&resulttype=core&format=json

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes

17 January 2020

cites work

https://api.crossref.org/works/10.1038/AJG.2010.363

1

1 reference

Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus

19 November 2024

https://api.crossref.org/works/10.1038/AJG.2010.363

2

1 reference

Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations

19 November 2024

https://api.crossref.org/works/10.1038/AJG.2010.363

3

1 reference

Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).

19 November 2024

https://api.crossref.org/works/10.1038/AJG.2010.363

4

1 reference

Incretin mimetics as a novel therapeutic option for hepatic steatosis

19 November 2024

https://api.crossref.org/works/10.1038/AJG.2010.363

5

1 reference

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

19 November 2024

https://api.crossref.org/works/10.1038/AJG.2010.363

6

1 reference

The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial

19 November 2024

https://api.crossref.org/works/10.1038/AJG.2010.363

7

1 reference

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

19 November 2024

https://api.crossref.org/works/10.1038/AJG.2010.363

8

1 reference

Benefit-risk assessment of exenatide in the therapy of type 2 diabetes mellitus

19 November 2024

https://api.crossref.org/works/10.1038/AJG.2010.363

9

1 reference

Exenatide-induced acute pancreatitis

19 November 2024

https://api.crossref.org/works/10.1038/AJG.2010.363

10

1 reference

19 November 2024

Identifiers

DOI

10.1038/AJG.2010.363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21131943%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference